Schonfeld Strategic Advisors LLC G1 Therapeutics, Inc. Transaction History

Schonfeld Strategic Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$2.1 - $4.83 $673,558 - $1.55 Million	-320,742 Reduced 94.12%	20,042 $86,000
Q4 2023 Feb 14, 2024	BUY	$1.12 - $3.73 $381,678 - $1.27 Million	340,784 New	340,784 $1.04 Million
Q2 2023 Aug 14, 2023	BUY	$2.46 - $3.14 $42,804 - $54,636	17,400 New	17,400 $43,000
Q3 2022 Nov 14, 2022	BUY	$5.17 - $16.99 $473,173 - $1.55 Million	91,523 New	91,523 $1.14 Million
Q2 2021 Aug 16, 2021	SELL	$19.57 - $26.32 $279,890 - $376,428	-14,302 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$17.58 - $32.59 $251,429 - $466,102	14,302 New	14,302 $344,000
Q4 2018 Feb 14, 2019	SELL	$16.51 - $51.33 $135,464 - $421,162	-8,205 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$43.15 - $67.97 $354,045 - $557,693	8,205 New	8,205 $429,000
Q2 2018 Aug 14, 2018	SELL	$35.06 - $51.17 $417,880 - $609,895	-11,919 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$19.05 - $41.76 $227,056 - $497,737	11,919 New	11,919 $442,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.